Company profile for EpiEndo Pharmaceuticals

NEW Drugs in Dev.: 1
PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

EpiEndo is a clinical stage pharmaceutical company developing a proprietary portfolio of drugs to address the huge global burden of chronic respiratory diseases. Over more than a decade our research into the disease etiology of chronic obstructive pulmonary disease (COPD) has led to our unique insights in inflammatory processes.Our new class of orally-available macrolide candidate NCEs show promise as first-in-class disease-mo...
EpiEndo is a clinical stage pharmaceutical company developing a proprietary portfolio of drugs to address the huge global burden of chronic respiratory diseases. Over more than a decade our research into the disease etiology of chronic obstructive pulmonary disease (COPD) has led to our unique insights in inflammatory processes.Our new class of orally-available macrolide candidate NCEs show promise as first-in-class disease-modifying therapeutics for COPD. Our lead compound is a non-antibiotic analogue of azithromycin which modulates inflammation through strengthening the lung epithelium.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Iceland
Address
Address
Borgartún 28, Reykjavik
Telephone
Telephone
[+354] 454 0090
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/12/08/3201212/0/en/EpiEndo-Pharmaceutical-s-ERJ-Open-Research-article-reports-first-clinical-trial-of-glasmacinal-EP395-in-COPD-patients.html

GLOBENEWSWIRE
08 Dec 2025

https://www.businesswire.com/news/home/20250611187825/en/Clinical-and-Pre-Clinical-Data-on-the-Novel-Barriolide-EP395-glasmacinal-Published-in-Three-Articles-in-Pulmonary-Pharmacology-and-Therapeutics

BUSINESSWIRE
11 Jun 2025

https://www.businesswire.com/news/home/20240410505161/en

BUSINESSWIRE
10 Apr 2024

https://www.businesswire.com/news/home/20221114005148/en

BUSINESSWIRE
14 Nov 2022

https://www.clinicaltrialsarena.com/news/epiendo-begins-copd-trial/

CLINICALTRIALSARENA
31 Aug 2022

https://www.businesswire.com/news/home/20220830005875/en

BUSINESSWIRE
31 Aug 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty